This cannabinoid bioavailability review looks at a 2025 crossover study testing a nanoemulsified THC/CBD powder against standard oil drops in healthy volunteers. The study found faster absorption and higher cannabinoid exposure with the powder formulation. But cannabinoid bioavailability is not the same as proven clinical benefit, and that distinction matters for patients, providers, and policymakers.
Cannabinoid Oral Mucosal Delivery: Approaches to Formulation, Fabrication, and Permeation Enhancement.
Cannabinoids such as cannabidiol (CBD) and tetrahydrocannabinol (THC) have garnered significant interest for their broad-spectrum pharmacological activity in…
United Center Becomes First Major US Arena to Partner with Cannabis Drink Brands
New research shows that combining lesser-known cannabinoids like CBDV and CBG produces stronger anti-inflammatory effects than any single compound alone, supporting the value of full-spectrum hemp products. Chicago’s United Center, the largest entertainment arena in the US, has entered a historic partnership with cannabis drink brands, establishing the first-ever official THC sponsorship at a major American venue. The deal with RYTHM Inc.